Navigation Links
Guard against heart attacks

According to researchers, a new study shows the anti-inflammatory drug naproxen may protect people against heart attacks. Naproxen is a non-steroidal anti-inflammatory drug (NSAID) commonly prescribed for the management of inflammatory and arthritic conditions. Researchers in Quebec studied the effects of naproxen versus other NSAIDs //in the prevention of acute myocardial infarctions (AMI), or heart attacks, in older patients. The study evaluated all patients in Quebec over age 65 who had been hospitalized between 1995 and 1998 for a heart attack.

Researchers found naproxen had a protective effect against AMI when compared with other NSAIDs. The effect was strongest in chronic users. The antiplatelet effect of naproxen appears to be brief and researchers say only persistent use may provide cardiac protection.

Researchers point out that the study does not compare the use of naproxen versus the commonly suggested course of aspirin for patients at risk for heart attacks, and the results should apply only to patients already in need of NSAID therapy.


'"/>




Page: 1

Related medicine news :

1. Diabetics Need to Guard Against Nail Fungus
2. People Need To Be More Guarded Against Skin Cancer
3. Moderate Drinking Does Not Guard Against Heart Disease
4. p53, the Guardian of Our Genome
5. Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU
6. Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU
7. Breastfeeding Mothers Need Calcium to Guard Against Periodontal Diseases
8. Estradiol Guards Against Osteoporosis
9. Delhi Police, Home Guards to Guard LNGP
10. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
11. Man against HIV – new vaccine ready for human trials
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Guard against heart attacks

Breaking Medicine Technology:GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4New Executive Leadership and CEO Announced for BiPar Sciences 2Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 1Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 2Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 3Study on keeping nuclear bombs from US ports shows misplaced fear over cargo scanning cost 12946 4Research shows that invisible hand guides evolution of cooperative turn taking 9182 1Research shows that invisible hand guides evolution of cooperative turn taking 9182 2Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 4702 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis 4702 2